The deal size was increased to $550M from $350M and priced below last closing price of $94.50. Morgan Stanley, Leerink, William Blair, Raymond James, Stifel and Truist are acting as joint book running managers for the offering.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on VKTX:
- Viking Therapeutics announces $350M common stock offering
- Viking Therapeutics price target raised to $116 from $46 at Oppenheimer
- Viking Therapeutics price target raised to $120 from $50 at Maxim
- Viking Therapeutics price target raised to $115 from $37 at Raymond James
- Viking Therapeutics price target raised to $80 from $35 at Stifel